| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850509 | American Journal of Kidney Diseases | 2009 | 10 Pages |
Abstract
Patients with CHD and CKD are at increased risk of cardiovascular events. Compared with usual care, focused atorvastatin treatment decreased cardiovascular risk for established patients in real-world settings, with no significant difference in treatment effects observed between patients with and without CKD.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Michael J. MD, Michael H. MD, Daniel J. MD, Rana S. PhD, Andrea MD, David P. MD, ALLIANCE Investigators ALLIANCE Investigators,